Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic General Population”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Not applicableStudy completedNCT04658381
What this trial is testing

Genetic Analysis and Multimodal Retinal Imaging of Asymptomatic Fovea Plana Cases in the General Population

Who this might be right for
Fovea PlanaAlbinism
Fondation Ophtalmologique Adolphe de Rothschild 20
Not applicableStudy completedNCT05641415
What this trial is testing

Finnish Imaging of Shoulder Study

Who this might be right for
Shoulder PainRotator Cuff TearsGlenoid Labrum Tear+1 more
University of Helsinki 603
Not applicableStudy completedNCT01615315
What this trial is testing

Aspirin and the Risk of Microscopic Hematuria in Asymptomatic Screened Population

Who this might be right for
Asymptomatic General PopulationMicroscopic Hematuria
Seoul National University Hospital 60,048
Not applicableNot Yet RecruitingNCT06276803
What this trial is testing

The LINFU® U.S. Registry for the in the General Population Without Risk Factors

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPancreatic Dysplasia
Adenocyte, LLC 500
Not applicableStudy completedNCT00002048
What this trial is testing

The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III)

Who this might be right for
Lymphatic DiseaseHIV Infections
Glaxo Wellcome